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Currently, it remains controversial how vascular
endothelial progenitor cells (angioblasts) establish
their arterial or venous fates. We show using zebra-
fish that the arterial progenitors of the major axial
vessels originate earlier and closer to the midline
than the venous progenitors. Both medial and lateral
progenitor populations migrate to distinct arterial
and venous positions and not into a common precur-
sor vessel as previously suggested. Overexpression
of VEGF or Hedgehog (Hh) homologs results in the
partially randomized distribution of arterial and
venous progenitors within the axial vessels. We
further demonstrate that the function of the Etv2
transcription factor is required at earlier stages for
arterial development than for venous. Our results
argue that the medial angioblasts undergo arterial
differentiation because they receive higher concen-
tration of Vegf and Hh morphogens than the lateral
angioblasts. We propose a revised model of arte-
rial-venous differentiation that explains how angio-
blasts choose between an arterial and venous fate.
INTRODUCTION
During the formation of the major blood vessels, vascular endo-
thelial progenitor cells (angioblasts) are thought to adopt an arte-
rial or venous identity prior to the initiation of circulation (Wang
et al., 1998; Zhong et al., 2001). Hedgehog (Hh), Vascular Endo-
thelial Growth Factor (VEGF), and Notch signaling pathways
have been implicated in proper arterial-venous specification
(Cleaver and Krieg, 1998; Jin et al., 2005; Lawson et al., 2001,
2002; Shoji et al., 2003; Swift and Weinstein, 2009; Weinstein
et al., 1995) in studies using multiple vertebrates including
mice, frog Xenopus laevis, and zebrafish. According to the cur-
rent model, notochord-derived Sonic Hedgehog (Shh) induces
expression of VEGF within the medial part of the somites.
VEGF signaling induces phospholipase C gamma-dependent196 Developmental Cell 25, 196–206, April 29, 2013 ª2013 Elsevier Iextracellular signal-regulated kinase phosphorylation and acti-
vates the expression of Notch and its ligand Delta within the arte-
rial precursors. This signaling pathway then acts to promote
arterial expression and repress venous expression. However, it
is not well understood how endothelial progenitor cells decide
to differentiate as an arterial or venous cell.
The zebrafish represents an ideal model system to study
arterial-venous differentiation due to its optical transparency
and amenability to genetic techniques (Laale, 1977). In zebrafish,
similar to other vertebrates, angioblasts originate within the
lateral plate mesoderm (LPM) and migrate over the endoderm
to the dorsal midline where they coalesce to form the dorsal
aorta (DA) and the posterior cardinal vein (PCV) (Childs et al.,
2002; Eriksson and Lo¨fberg, 2000; Jin et al., 2005; Lawson and
Weinstein, 2002; Williams et al., 2010). Angioblasts have been
described to migrate in two waves to the dorsal midline. It has
been suggested that the angioblasts in the first migrating wave
coalesce and contribute to the DA, while the second-wave
angioblasts contribute to the PCV (Fouquet et al., 1997; Jin
et al., 2005; Williams et al., 2010). In addition, it was shown
that at least some of the venous endothelial cells migrate to
the PCV after 21 hpf from the dorsally positioned vascular cord
by the mechanism of ventral sprouting (Herbert et al., 2009).
However, definitive evidence for the contribution of the first-
and second-wave angioblasts to the DA and PCV is still missing.
The origin of arterial and venous progenitors and their assem-
bly into the major axial vessels remain controversial. Earlier
studies have suggested that the arterial-venous fates of angio-
blasts are predetermined prior to migration and that the progeny
of a single angioblast can contribute to either an arterial or
venous lineage, but never both (Zhong et al., 2001). It was sug-
gested that angioblasts migrate directly to either the position
of the DA or the PCV and coalesce to form two distinct vessels.
Recently, it was proposed that all angioblasts initially coalesce
into a single vascular cord located at the position of the DA,
and at 21 hpf angioblasts located in the DA primordia ventrally
sprout to form the first embryonic vein through the mechanism
of ventral sprouting (Herbert et al., 2009). Despite these different
models for vessel formation, it is still not known how angioblasts
coalesce to form the DA and PCV, and whether arterial and
venous precursors originate from a common location or from
distinct regions within the LPM.nc.
Figure 1. Medial and Lateral Angioblasts
Originate in Two Distinct Regions, as Ob-
served by ISH Analysis for etv2 Expression
(A–L) etv2, flk1/kdrl, and fli1a expression analysis
in trunk angioblasts at the 10-, 15-, 18-, and
22-somite stages. etv2 expression is observed
in the medial (arrowheads) and lateral (arrows)
angioblasts. flk1/kdrl and fli1a expression is initially
restricted to the medial angioblasts (B and C)
with very weak observed expression in the lateral
angioblasts in 15- to 22-somite stage embryos
(E–K; F–L).
(M–O) etv2 expression in migrating medial angio-
blasts at the 11- to 14-somite stages. Note that the
migration wave progresses in the anterior to pos-
terior direction. The lateral angioblasts migrate
later at the 16- to 22-somite stages (G and J).
Dorsal view of the trunk and tail region of flat-
mounted embryos. Anterior is to the left. Scale
bar, 100 mm.
See also Figures S1 and S2, and Movies S1, S2,
S3, and S4.
Developmental Cell
Origin of Arterial and Venous ProgenitorsIn addition to the extrinsic molecular signals such as Hh and
VEGF, cell-autonomous factors also play an important role in
the differentiation and migration of endothelial progenitors. We
and others have demonstrated that a transcription factor, Etv2/
Etsrp/ER71, functions as a master regulator controlling vasculo-
genesis (Lee et al., 2008; Pham et al., 2007; Sumanas et al.,
2005, 2008; Sumanas and Lin, 2006; Wong et al., 2009). Etv2
encodes an ETS domain transcription factor and is one of the
earliest markers expressed in endothelial progenitor cells. Etv2
function is required to initiate expression of multiple endothe-
lial-specific genes including VEGF receptor kdrl/flk1/vegfR2. In
etv2 morphants, angioblasts fail to differentiate, migrate, or
coalesce to form functional vessels, demonstrating the impor-
tance of this transcription factor in axial vessel development
(Pham et al., 2007; Sumanas and Lin, 2006).
In this study, we performed fatemapping and lineage tracing in
live zebrafish embryos to determine the origin of arterial and
venous progenitors of the major axial vessels, and their pattern
of migration and assembly into the DA and the PCV. Contrary
to the current model suggesting that angioblasts originate from
a common location within the LPM, we show that two distinct
endothelial progenitor populations (medial and lateral) are pre-
sent within this region. The medial angioblasts migrate to the
midline first, followed by the lateral angioblasts. Cell tracking of
migrating medial and lateral angioblasts shows that the majority
of endothelial progenitor cells directly migrate from the LPM to
distinct dorsal and ventral positions and do not coalesce into a
common precursor vessel as previously suggested (Herbert
et al., 2009). We show through fate mapping and lineage tracing
that the arterial and venous cells of the DA and the PCV originate
from different pools of endothelial progenitors, medial and lateral
angioblasts. The medial angioblasts contribute almost exclu-
sively to the DA, while the lateral angioblasts give rise to the
PCV. Our results further argue that the medial angioblasts
acquire arterial fate because they are closer to the midline and
are exposed to the higher concentrations of Vegf and Hh mor-
phogens; overexpression of Vegf and Hh partially randomizesDevethe contributions of medial and lateral angioblasts to the DA
and the PCV. Therefore, this study revises the current model of
arterial-venous differentiation and explains the mechanism by
which endothelial progenitors decide between arterial and
venous fate during the formation of the major axial vessels.
RESULTS
Two Distinct Endothelial Progenitor Populations
Originate in the LPM
In this study, we aimed to identify when and where arterial and
venous precursors of the major axial vessels originate, and to
determine how they migrate and coalesce to form the DA and
the PCV. To observe angioblasts during the earliest stages of
development, we utilized the expression of a transcription factor,
Etv2/Etsrp/ER71, which is one of the earliest markers expressed
in the angioblasts, and functions as a master regulator of vascu-
logenesis (Lee et al., 2008; Pham et al., 2007; Sumanas et al.,
2005, 2008; Sumanas and Lin, 2006; Wong et al., 2009). Knock-
down of etv2 results in the downregulation of multiple vascular
markers including flk1/kdrl, arterial-specific gridlock/hey2 (grl)
and ephrin B2a (efnb2a), and venous-specificmannose receptor
C1 (mrc1) and ephB4a (Figures S1C–S1F available online) (Pham
et al., 2007; Sumanas and Lin, 2006; Wong et al., 2009). From
in situ hybridization (ISH) analysis, etv2 expression is observed
in a single line of angioblasts within the LPM of the trunk region
as early as the 4-somite stage (Figures S1A and S1B) (Sumanas
and Lin, 2006). However, beginning at the 10-somite stage a
second line of etv2-expressing angioblasts is observed posi-
tioned further away from the midline (Figures 1A, 1D, 1G, 1J,
and 1M–1O). The more medially located angioblasts migrate to
the midline first starting between the 9- to 10-somite stages
(Figure 1A), and continue to migrate (Figures 1M–1O) until the
15-somite stage when nearly all medial angioblasts in the trunk
region have reached the midline (Figure 1D). Interestingly, the
more posterior medial angioblasts remain bilaterally located
within the LPM (Figure 1D) and migrate later than the anteriorlopmental Cell 25, 196–206, April 29, 2013 ª2013 Elsevier Inc. 197
Figure 2. Two-Color ISH Expression Anal-
ysis of etv2 and Other Endothelial and
Hematopoietic Markers
ISH expression of (A and B) etv2 and gata1 at the
15-somite stage, (C) etv2 and kdrl at the 16-somite
stage, (D) etv2 and scl at the 10-somite stage, and
(E and F) etv2 and grl at the 16-somite stage.
(A and B) Erythroid-specific gata1 expression
(white arrows) is positioned between the medial
(arrowheads) and lateral (black arrows) etv2-ex-
pressingangioblasts; (B) highermagnificationview.
(C) etv2 and kdrl expression overlaps at the
midline (arrowhead) in the medial angioblasts.
While strong etv2 expression is seen in the lateral
angioblasts (arrow), no or very little lateral kdrl
expression is observed.
(D) Relative to vascular endothelial progenitor cells,
erythroid-specific scl expression (white arrows) is
positioned between the medial (arrowheads) and
lateral (black arrows) etv2-expressing angioblasts.
(E and F) Similar to (C), grl expression overlaps
with etv2 expression in medial angioblasts at the
midline (arrowheads). Lateral angioblasts are grl-
negative (arrows). Note that the strong bilateral grl
expression (*) does not correspond to endothelial
cells and is within the somitic tissue as reported
previously (Zhong et al., 2000).
See also Movies S1, S2, S3, and S4.
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beginning at the 16-somite stage, and most complete their
migration by the 22-somite stage (Figures 1D, 1G, and 1J). These
data suggest that the earlier and later migrating angioblasts orig-
inate at distinct times and locations.
From flk1/kdrl (Figures 1B, 1E, 1H, and 1K) expression analysis
at the 10-somite stage (Thompson et al., 1998), only the medial
angioblasts are observed (Figure 1B), and expression in the
lateral angioblasts is not apparent until the cells have initiated
migration (Figures 1E, 1H, and 1K). As evident from two-color
ISH (Figure 2C), etv2 and flk1/kdrl expression overlaps in the
medial angioblasts at the 16-somite stage. The lateral angio-
blasts, however, show strong etv2 expression and weak to no
flk1/kdrl expression. Midline etv2 expression also overlaps with
arterial grl/hey2 (Zhong et al., 2000) expression (Figures 2E and
2F), while the lateral angioblasts are grl negative (arrows). Inter-
estingly, expression of the erythroid-specific markers scl/tal1
and gata1 (Detrich et al., 1995; Gering et al., 1998; Liao et al.,
1998) is positioned between the medial and lateral lines of
etv2-expressing angioblasts (Figures 2A, 2B, and 2D). Similar
to flk1/kdrl expression, the vascular endothelial marker fli1a
(Thompson et al., 1998) is initially restricted to the medial angio-
blasts at the 10-somite stage (Figure 1C), with very weak expres-
sion in the lateral angioblasts in 15- to 22-somite stage embryos
(Figures 1F, 1I, and 1L). The wider fli1a expression at the 10-
somite stage is likely due to its early expression in both endothe-
lial and erythroid precursors.
To study angioblast migration, we utilized an established
etv2:GFP transgenic reporter line that differentially labels all
angioblasts (Proulx et al., 2010). While GFP expression is readily
apparent in the medial angioblasts (Figure 3; Movie 1), there is
a delay in GFP expression in the lateral precursors (Figures 3F
and 3G). This is presumably due to the additional time required198 Developmental Cell 25, 196–206, April 29, 2013 ª2013 Elsevier Ifor the translation and folding of GFP protein in the lateral angio-
blasts that originate later. Interestingly, endothelial precursor
cells migrate intersomitically to the midline in an anterior to
posterior sequence (Figures 1A, 1M–1O, and 2B–2G; Movies 1
and 2). Initially angioblasts cluster around somites, and at the
time of migration ingress between the boundaries of adjacent
somites (Figure S2A). This intersomitic migration of angioblasts
was confirmed by photoactivating angioblasts in embryos in-
jected with Kaede mRNA, thereby converting Kaede protein in
the cell from green to red fluorescence (Ando et al., 2002; Hatta
et al., 2006; Stark and Kulesa, 2007; Watanabe et al., 2007) (Fig-
ures S2B–S2F; Movie 3). Such pattern of migration can also
be observed in the fli1a:GFP reporter line (Lawson and Wein-
stein, 2002) (Figures S2G–S2J; Movie 4). However, fli1a:GFP
is also expressed in erythroid precursors during early somito-
genesis stages, and time-lapse imaging would capture both
cell populations.
Medial Angioblasts Contribute to the DA, while Lateral
Angioblasts Give Rise to the PCV
Based on the etv2 expression pattern, we hypothesized that
the medial angioblasts differentiate as arterial progenitors and
contribute to the DA, while the lateral angioblasts undergo
venous differentiation and contribute to the PCV. To perform
fate mapping of the medial and lateral angioblasts, we used
BAC modification to establish an etv2:Kaede line that expresses
the photoconvertible Kaede protein under the etv2 promoter.
Similar to etv2:GFP expression, etv2:Kaede expression pattern
was localized to vascular endothelial progenitors (Figure S3).
Many embryos displayed a mosaic expression pattern, likely
due to epigenetic silencing that is commonly observed in
transgenic lines (Goll et al., 2009). Because the lateral angio-
blasts originate later than the medial progenitors, and the Kaedenc.
Figure 3. The Migration of Trunk Angioblasts in Live etv2:GFP-Transgenic Embryos
(A–G) GFP expression is observed in the medial and lateral endothelial progenitor cells at the 10- to 16-somite stages. In laterally (A) and dorsally mounted
embryos (B–G), medial angioblasts (white arrows) migrate toward the midline (white arrowheads) intersomitically.
(B–G) Selected frames from a time-lapsemovie showingmigration of themedial angioblasts; imagingwas started at the 10-somite stage. The anterior angioblasts
migrate first, followed by the more posterior endothelial progenitor cells.
(F and G) Faint GFP expression in the lateral angioblasts (red arrowheads) becomes apparent; these cells migrate to the midline similar to the medial angioblasts.
In (A) anterior is to the left; in (B)–(G) anterior is up. Scale bar, 100 mm. See also Figure S2 and Movies S1, S2, S3, and S4.
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lateral angioblasts was largely not apparent until after the 15-
to 16-somite stages (Figure S3). This allowed us to label all
medial angioblasts by exposing the whole etv2:Kaede-positive
embryo to UV epifluorescence at the 15- to 16-somite stages.
The position of the photoconverted cells was subsequently
analyzed at 25–28 hpf, after the DA and PCV have formed.
The majority (98%) of the vascular endothelial cells present
in the trunk region of the DA were fluorescent for both red
and green, indicating that they originated prior to the photo-
conversion and are derived from the medial angioblasts
(Figures 4A, 4B, and 4I). Because Kaede synthesis continues
after photoconversion, labeled cells display both green and
red fluorescence. Only 2% of cells in the trunk region of the
DA displayed green-only fluorescence and had no red Kaede
protein. In contrast, 92% cells in the PCV displayed green
fluorescence only, indicating that they originated after the
photoconversion and were derived from the lateral line angio-
blasts. Only 8% of the cells within the PCV displayed both
red and green fluorescence (Figures 4A, 4B, and 4I). In addition
to the flat elongated vascular endothelial cells, etv2:Kaede
expression was observed in round nonendothelial cells, which
most likely correspond to hematopoietic progenitors such as
neutrophils (data not shown); these cells were excluded from
the analysis.
These results suggest that the medial angioblasts contribute
predominantly to the DA, while the lateral progenitors largely
give rise to the PCV. The small number of red photoconverted
cells present in the PCV are likely either the medial cells
migrating to the PCV by the ventral sprouting as previously
described (Herbert et al., 2009), or the lateral cells that origi-
nated earlier and were labeled during whole-embryo photocon-
version. To investigate these possibilities, we photoactivated
clusters of the medial angioblasts using a 405 nm laser source
(Figure 4C). In all cases (n = 11 embryos analyzed, two to three
cell clusters per embryo), the endothelial progeny of the labeled
cells were detected exclusively within the DA or in the DA-
derived intersegmental vessels (Figure 4D). These results argue
that the medial angioblasts give rise to the DA, while the lateral
angioblasts form the PCV. Therefore, arterial and venous pro-
genitors of the major axial vessels originate in distinct locations
within the LPM.DeveHh and Vegf Gradient Is Critical for Arterial-Venous
Contribution of the Medial and Lateral Angioblasts
Hh and Vegf signaling pathways have been previously implicated
in arterial-venous differentiation (Lawson et al., 2002). In zebra-
fish, sonic hedgehog (shh) is expressed in the floorplate and
the neural tube, while vegfa expression is localized to the hypo-
chord and the ventral part of the somites (Krauss et al., 1993;
Liang et al., 1998, 2001). Thus, both VegfA and Shh are localized
close to the midline and may function as morphogens. Because
medial angioblasts are located closer to the midline, they are
likely to be exposed to higher levels of Vegf and Hh concentra-
tions and therefore differentiate as arterial cells, while lateral
angioblasts would experience lower concentrations and there-
fore adopt a venous fate. To test this hypothesis, we altered
Vegf and Hh levels by injecting synthetic zebrafish VegfA and
ShhmRNAs into etv2:Kaede embryos at the 1-cell stage. As pre-
viously reported, VegfA and Shh overexpression resulted in the
expansion of arterial markers (data not shown) (Lawson et al.,
2002), and Shh-overexpressing embryos displayed additional
expected phenotypes such as inhibition of lens differentiation
(Ekker et al., 1995). As analyzed by whole-embryo photoconver-
sion assay, both Vegf and Shh overexpression resulted in amore
random fate choice of medial and lateral angioblasts. In contrast
to wild-type embryos, in Vegf- and Shh-overexpressing embryos
photoconverted red and green-positive Kaede cells were pre-
sent in both the DA and the PCV (Figures 4E, 4G, and 4I).
Similarly, green-only lateral endothelial cells were present in
both the DA and the PCV as well. Because Vegf- and Shh-over-
expressing embryos do not form functional vasculature, the
distinction between the DA and the PCV in this analysis is based
on the dorsoventral position of the cells within the axial vascula-
ture. We also analyzed dorsoventral distribution within the axial
vessels of medial and lateral angioblasts in VegfA morpholino
(MO)-inhibited embryos (morphants). Consistent with previous
reports (Lawson et al., 2002; Nasevicius et al., 2000), VegfA mor-
phants formed a single vessel and failed to initiate circulation.
Interestingly, photoconverted medial angioblasts were predom-
inantly positioned at the dorsal side of this vessel, while lateral
angioblasts cells remained ventrally positioned (Figures 4F and
4I). This may be explained by possible redundancy between
Hh and Vegf signaling or incomplete inhibition of Vegf function
using morpholinos (see Discussion). To test how the inhibitionlopmental Cell 25, 196–206, April 29, 2013 ª2013 Elsevier Inc. 199
Figure 4. The Medial Angioblasts Give Rise to the Dorsal Aorta,
while the Lateral Angioblasts Give Rise to the Posterior Cardinal Vein
In all experiments, etv2:Kaede embryos were photoconverted at the 14- to 15-
somite stages and analyzed at 24–28 hpf. Anterior is to the left; dorsal is up in
all panels.
(A and B) Global green to red photoconversion of etv2:Kaede-positive cells
demonstrates that all early Kaede+ endothelial progenitor cells that were pho-
toconverted contribute to the DA (observed as an overlap of red and green
fluorescence), while all late Kaede+ cells that originated after photoconversion
contribute to the PCV (observed as green-only fluorescence). Note that etv2:
Kaedeexpressionpattern ismosaic, andnotall endothelial cells expressKaede.
In addition, etv2:Kaede is expressed in certain hematopoietic lineages such as
neutrophils (red round cells in A and B), whichwere not included in the analysis.
(C and D) Selected groups of medial etv2:Kaede cells were photoconverted
using laser confocal microscopy at the 15-somite stage (arrow, C), and their
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200 Developmental Cell 25, 196–206, April 29, 2013 ª2013 Elsevier Iof Hh signaling affected the migration of the medial and lateral
angioblasts, we analyzed their position in cyclopamine-treated
embryos. The distribution of vascular endothelial cells in the
trunk axial vasculature region was disorganized, and in some re-
gions the cells failed to form a distinct DA and PCV. The majority
of the red photoconverted cells were positioned at the dorsal
side of the disorganized vascular cord, while the green lateral-
line-derived endothelial cells were present in both dorsal and
ventral positions (Figure 4H). Vegf RNA, Vegf MO injection, or
cyclopamine treatment did not significantly affect the initial for-
mation of the medial and lateral line angioblasts as observed
by etv2 ISH expression analysis at the 10- to 15-somite stages
(data not shown). Overall, these results argue that Shh and
Vegf concentration is one of the critical factors in determining
arterial-venous contribution of angioblasts. RNA overexpression
disturbs the normal gradient and leads to the partial randomiza-
tion of the cell fate choice in comparison to wild-type embryos.
Angioblasts Migrate Directly to Their Arterial and
Venous Positions
To determine how medial and lateral angioblasts migrate to
their positions within the DA and the PCV, we performed time-
lapse imaging of migrating angioblasts in Tg(etv2:GFP) andlocation was analyzed at 26–28 hpf (arrows, D) using fluorescence micro-
scopy. Note that the labeled medial cells exclusively contribute to the DA,
including DA-derived intersegmental vessels (ISV, D). Arrowheads in (C) point
to the cells of the lateral line. Red round cells apparent on the right side of (D)
correspond to etv2:Kaede expression in hematopoietic lineages. Panels in (C)
and (D) represent different embryos.
(E) Global photoconversion of etv2:Kaede in VegfA-RNA-overexpressing
embryos. Note that the cells in the DA and PCV positions include both double-
positive (red and green) medial-line-derived endothelial cells and green-only
lateral-line-derived endothelial cells (arrowheads).
(F) VegfA MO-injected embryos display a single vessel, as observed by global
etv2:Kaede photoconversion. Double-positive (red and green) medial-line-
derived endothelial cells are largely located in the dorsal most part of the
vessel, while green-only lateral-line-derived cells are found largely in the
ventral part of the vessel.
(G) Shh RNA-injected etv2:Kaede globally photoconverted embryos display a
significant number of green-only lateral-line-derived cells in the DA (arrow-
head) and occasional medial-line-derived cells in the PCV (arrow, points to a
small double-positive endothelial cell).
(H) Cyclopamine (CyA)-treated etv2:Kaede globally photoconverted embryos
have disorganized cells within the vascular cord often with no discernable
distinction between the DA and the PCV. Higher frequency of green-only cells
can be observed in the dorsal part of the vessel (arrowheads).
(I) Average contribution of medial (red) and lateral (green) globally photo-
converted etv2:Kaede cells to the DA and the PCV in wild-type (n = 13 embryos
and 335 endothelial cells analyzed), VegfA RNA (n = 17 embryos and 417 cells),
Vegf MO (n = 10 embryos and 295 cells), Shh RNA-injected (n = 17 embryos
and 247 cells), and CyA-treated (n = 8 embryos and 88 cells) embryos. Cell
counts for each embryo are approximate estimates. Embryos treated with 1%
DMSO (solvent for CyA) displayed distribution of green and red Kaede+
cells, similar to WT (not shown). In addition to the flat elongated vascular
endothelial cells, etv2:Kaede expression was observed in round non-
endothelial cells, which most likely correspond to hematopoietic progenitors
such as neutrophils (data not shown); these cells were excluded from the
analysis. *Statistically significant differences, as calculated using Z-test for two
proportions to compare the percentage of green cells contributing to the DA
or the percentage of red cells contributing to the PCV between the treated
embryos and wild-type controls (p% 0.001).
See also Figure S3.
nc.
Figure 5. Migration of Medial and Lateral
Angioblasts to the DA and PCV Observed
in Live etv2:Kaede Embryos
Selected frames from a time-lapse movie of a
single etv2:Kaede embryo prephotoconversion at
the 14-somite stage (A) and postphotoconversion
starting at the 15-somite stage (B) through 28 hpf
(F). Arrows mark laterally positioned angioblasts
that migrate directly to a ventral position to
contribute to the PCV. Arrowheads mark a sepa-
rate population of lateral angioblasts that con-
tribute directly to the common cardinal vein (CCV).
All views are dorsolateral; anterior is to the left, and
dorsal is to the top. All selected frames are from
Movie 6, embryo 1; imaging (t = 0 min) was started
at approximately 13-somite stage.
See also Movies S5, S6, S7, and S8.
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individual medial angioblasts migrate from the LPM directly to
the dorsal position where they coalesce and form the DA (Fig-
ure 5; Movies 5, 6, and 7). The lateral angioblasts initiate migra-
tion to the midline after the 15-somite stage and migrate directly
to a ventral position where they coalesce into the PCV (Figure 5;
Movie 7). Interestingly, some lateral angioblasts migrate much
later at the 22- to 24-somite stages and intercalate into the
ventral part of the already formed venous vascular cord (Movie
8). It is apparent from these data that arterial and venous progen-
itors originate in distinct locations. This is particularly evident in
the anterior region where the common cardinal vein (CCV) forms,
which is separated from the DA at a greater distance since CCV
progenitors stay bilaterally and do notmigrate toward themidline
(Figure 5; Movie 7). Based on these cell-tracking results, the
majority of the medial and lateral angioblasts migrate from the
LPM directly to distinct dorsal and ventral positions, forming
two separate vessels.
Etv2 Function Is Required Earlier for Arterial
Differentiation than for Venous
If lateral angioblasts preferentially contribute to the venous line-
age, then the inhibition of lateral endothelial cell differentiation
should result in greater venous patterning defects. Since etv2
expression is not observed in the lateral angioblasts until the
10-somite stage (Sumanas and Lin, 2006) (Figures 1A, S1A,
and S1B), suppression of etv2 function at this stage should
selectively inhibit the differentiation and migration of the lateral
endothelial precursor cells. To inhibit etv2 function at selected
developmental stages, we used etv2 MO that was hybridized
to a caging strand containing a photocleavable linker (Tomasini
et al., 2009). In control experiments, both caged and regular
etv2 MOs resulted in similar inhibition of reporter etv2:GFP
expression (Figures S4A–S4C). In caged MO-injected embryos
that were never photoactivated, some inhibition of etv2:GFP
expression was observed; however, these embryoswere pheno-
typically normal and displayed no circulation defects (Fig-
ure S4D; data not shown).
We analyzed when etv2 function was required for vascular
development. As expected, etv2 caged MO-injected embryos
uncaged at the sphere stage (4 hpf) displayed strong downregu-
lation of flk1/kdrl expression throughout the embryo (Figures 6A–
6C). Embryos uncaged at the 10-somite and 15-somites stageDeveshowed less severe phenotypes (Figures 6D and 6E); however,
differential effects on the arterial and venous marker expression
were observed. Flk1/Kdrl expression in the DA was weakly
affected, while venous expression was greatly reduced (Fig-
ure 6D). Uncaging embryos at the 20-somite stage and later
resulted in no apparent defects in flk1/kdrl expression, blood
circulation, or intersegmental vessel formation at 1–2 dpf (data
not shown). This suggests that etv2 may not be required after
the 20-somite stage for vasculature formation, or the amount
of Etv2 protein already present in the cells might be sufficient
for its later function. We have previously shown that etv2 RNA
expression is retained or even upregulated in etv2 morphants
(Sumanas and Lin, 2006), which can be used to analyze the loca-
tion of etv2-expressing cells. As analyzed for etv2 expression in
etv2 morphants at 22- to 24-somite stages, embryos uncaged
at the sphere and 5-somite stages showed complete loss of
angioblast migration (Figures S4E–S4H). In embryos that were
uncaged at the 10-somite stage, the medial angioblasts migrate
normally, while the lateral angioblasts migration is inhibited (Fig-
ure S4H). These data suggest that the migration of lateral angio-
blasts can be selectively inhibited when etv2 MO embryos are
uncaged at the 10-somite stage.
To determine when etv2 function is required for arterial and
venous differentiation, embryos were injected with caged etv2
MO and photoactivated at the 30% epiboly, 7-, 13/14-, and
16/17-somite stages. Activated embryos were raised to 24 hpf
and analyzed for arterial expression of hey2/gridlock (grl) and
venous expression of mannose receptor C1 (mrc1) (Wong
et al., 2009; Zhong et al., 2000, 2001) by ISH. As expected, pho-
toactivation at the 30% epiboly stage resulted in the absence of
grl ormrc1 expression in the DA or PCV (Figures 6F–6I; Table 1).
However, uncaging at the 7-somite stage resulted in the partial
formation of the DA (Figure 6J; Table 1), while the PCV was
largely absent (Figure 6K; Table 1). Etv2 MO uncaging at the
13- to 17-somite stages had little effect on the patterning of
the DA (Figures 6L and 6N; Table 1); however, the PCV remained
incompletely formed (Figures 6M and 6O; Table 1). Normal DA
and PCV development was observed in embryos that were never
uncaged (Figures 6P and 6Q; Table 1). These results demon-
strate that the presence of Etv2 protein is required later for
venous differentiation than for arterial differentiation, and that
lateral angioblasts, which originate later, contribute predomi-
nantly to the venous vasculature.lopmental Cell 25, 196–206, April 29, 2013 ª2013 Elsevier Inc. 201
Figure 6. Arterial-Venous Differentiation Is Affected by Etv2 Func-
tion at Distinct Time Points
(A–E) flk1/kdrl expression analysis at 22 hpf stage. Control uninjected (A), MO-
injected but never uncaged (B), uncaged at the sphere (C), 10-somite (D), and
15-somite (E) stage embryos. Note that both the dorsal aorta (arrows) and the
posterior cardinal vein (arrowheads) are absent in (C); the dorsal aorta is
partially (D) or fully present (E), while the vein is greatly reduced or absent.
(F–Q) Arterial grl (F, H, J, L, N, and P) and venous mrc1 (G, I, K, M, O, and Q)
expression at 24 hpf in photoactivatable etv2MO-injected embryos. (F and G)
Control uninjected, (H and I) uncaged at 30%epiboly, (J and K) 7-somite stage,
(L and M) 13 to 14-somite stage, (N and O) 16- to 17-somite stage, and (P and
Q) MO-injected but never uncaged embryos. Note that arterial grl expression
(arrows) is absent in (H) but is partially present in (J) and not significantly
affected when MO is photoactivated at the 13- to 17-somite stages (L and N).
Venous mrc1 expression (arrowheads) is absent or strongly reduced in both
early (I and K) and late photoactivated embryos (M and O). Scale bar, 100 mm.
See also Figure S4.
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In this study, we demonstrate that etv2 expression marks two
populations of angioblasts within the posterior LPM, which orig-
inate at distinct time points and are positioned at different dis-
tances from the dorsal midline. By performing cell labeling and
fate mapping, we show that the medial angioblasts correspond
to the arterial progenitors of the DA, while lateral angioblasts
give rise to the venous endothelial cells of the PCV. We further
show that the majority of angioblasts migrate directly from the
LPM either to the DA or to the PCV. Both Vegf and Shh concen-
trations are important for the proper contribution of both pools of
angioblasts to the DA and the PCV.
Based on our results, we propose a revised model for arterial-
venous differentiation (Figure 7). Angioblasts originate within the
LPM in two bilateral lines, medial and lateral. Etv2 expression in
the medial angioblasts is observed as early as the 3-somite
stage, while expression in the lateral angioblasts is apparent
by the 10-somite stage. Beginning at around the 10-somite
stage, the medial angioblasts migrate intersomitically to the
midline over the endoderm in the anterior to posterior sequence
(Figure 7). After the 15-somite stage, the lateral precursors
initiate migration, with a migrational behavior similar to that of
the medial angioblasts. From the fate-mapping data, the medial
angioblasts contribute exclusively or almost exclusively to the
DA, while the lateral angioblasts give rise to the PCV. These
results argue that arterial and venous progenitors originate at
distinct time points and spatial regions.
It is currently unknown when angioblasts commit to an arterial
or venous fate. While our data show that arterial and venous
progenitors originate from distinct spatial regions, it is likely
that angioblasts do not acquire an arterial or venous fate until
later developmental stages. Based on our own unpublished
observations, and previously described expression patterns,
medial progenitors express both arterial (grl, efnb2a, and cldn5b)
(Lawson et al., 2001; Thisse and Thisse, 2004; Zhong et al., 2000)
and venous (mrc1, flt4, stab1l, and stab2)markers (Hogan et al.,
2009; Thompson et al., 1998; Wong et al., 2009) between the 10-
to 20-somite stages. Starting at the 20-somite stage in the
lateral-line-derived venous progenitors, arterial marker expres-
sion is gradually downregulated, while venous markers are upre-
gulated. Notch3 expression is also first apparent in the forming
DA at or close to the 20-somite stage (Lawson et al., 2001).
Therefore, this time point when the majority of angioblasts
have migrated to the midline, likely represents the stage when
arterial and venous fates are being specified.
Factors that induce arterial differentiation such as Vegf and Hh
are expressed close to the midline. In zebrafish, VegfA is ex-
pressed in the medial part of the somites, while Shh is secreted
from the notochord and the floorplate (Krauss et al., 1993; Liang
et al., 1998, 2001). Until now, it was not known why some angio-
blasts differentiate as arterial cells and others as venous cells if
they are all exposed to similar concentrations of morphogens.
Since we demonstrate that arterial precursors originate closer
to the midline, while venous progenitors are located further
away, this suggests that the medial angioblasts are likely
exposed to a higher concentration of Vegf and Hh morphogens,
and therefore differentiate as arterial cells. In agreement with this
model, both medial and lateral angioblasts migrate more or lessnc.
Table 1. Etv2 Function Is Required at Earlier Stages for Arterial grl Expression and at Later Stages for Venousmrc1 Expression
grl Expression, 24 hpf Normal Dorsal Aorta Reduced/Fragmented Dorsal Aorta Absent Dorsal Aorta Number of Embryos
Control uninjected 100% 0 0 40
Etv2 MO uncaged at 30% epiboly 0 4% ± 4% 96% ± 4% 30
7-somite 65% ± 15% 35% ± 15% 0 23
13- to 14-somite 92% ± 2% 8% ± 2% 0 24
16- to 17-somite 100% 0 0 23
Never uncaged 100% 0 0 25
mrc1 Expression, 24 hpf Normal Cardinal Vein Reduced Cardinal Vein Absent Cardinal Vein Number of Embryos
Control uninjected 100% 0 0 40
Etv2 MO uncaged at 30% epiboly 0 0 100% 30
7-somite 0 100% 0 30
13- to 14-somite 33% ± 4% 67% ± 4% 0 25
16- to 17-somite 33% ± 8% 67% ± 8% 0 19
Never uncaged 88% ± 9% 12% ± 9% 0 40
Data represent an average from two independent experiments. grl and mrc1 expression analyzed at 24 hpf ± refers to the SE.
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expression. Previous studies have shown that VegfA and Shh
overexpression results in the expansion of arterial markers into
the PCV and downregulation of venous markers within the DA
(Lawson et al., 2002) that, together with our findings, argues
that both pools of angioblasts acquire arterial fate upon Vegf
and Hh overexpression. The observed more random distribution
of angioblasts is likely caused by large amounts of ectopic VegfA
and Shh overriding the endogenous gradients. Interestingly,
even upon inhibition of VegfA and Hh signaling, many medial
angioblasts still migrated to the dorsal position, while lateral
angioblasts were preferentially localized to the ventral part of
the disorganized vascular cord. Because recent studies indicate
that Vegf and Hh have independent roles in arterial-venous dif-
ferentiation (Wilkinson et al., 2012; Williams et al., 2010), it is
possible that there is a redundancy between the two signaling
pathways, and just one of them is sufficient to guide angioblasts
to the arterial or venous position. In addition, chemical or mor-
pholino-mediated inhibition may not be complete, and minor
amounts of these morphogens remaining may be sufficient to
establish a partial gradient. An alternative scenario is that neither
Vegf nor Hh are absolutely required for angioblasts to migrate to
their dorsoventral positions within the DA or PCV. Because of the
sphere-like shape of a zebrafish embryo during somitogenesis
stages, lateral angioblasts are initially located more ventrally in
comparison to the medial angioblasts. Thus, in Vegf and Hh-
inhibited embryos they may largely stay in the more ventral
position corresponding to the PCV after the vascular cord has
formed. Nevertheless, profound vascular defects are observed
in Vegf- or Hh-inhibited embryos. Our findings support the
mechanism that medial angioblasts acquire arterial fate due to
their proximity to the sources of Vegf and Hh expression, and
thus provide an explanation how angioblasts decide between
the arterial and venous fates.
Previous studies have implicated Vegf signaling in multiple
steps in cardiovascular development, including arterial-venous
differentiation, hematopoietic stem cell (HSC) specification,
and angiogenic sprouting of intersegmental vessels (Covassin
et al., 2006; Lawson et al., 2002; Leung et al., 2013; SerbedzijaDeveet al., 1999; Zygmunt et al., 2011). VegfA performs different func-
tions at distinct time points, possibly mediated by distinct Vegf
isoforms. For instance, in Xenopus laevis, the VegfA170 isoform
has been implicated in HSC induction (Leung et al., 2013). Based
on previous studies and our own unpublished observations, both
major VegfA zebrafish isoforms, VegfA121 and VegfA165 can
induce arterial differentiation (Lawson et al., 2002; Liang et al.,
2001). However, the specific requirement for each isoform in
arterial-venous differentiation is unknown.
Although lateral angioblasts are initially positioned further
away from the midline, they eventually migrate through the
somitic mesoderm where VegfA is highly expressed. What then
prevents these angioblasts from acquiring arterial fates during
their migration? Because the lateral angioblasts originate and
migrate toward the midline later than the medial angioblasts,
this timing may be important for arterial-venous specification.
Indeed, our results show that Etv2 function is required at distinct
time points for arterial and venous specification that correspond
to the stages whenmedial and lateral progenitors undergo endo-
thelial differentiation. Since etv2 function is required to initiate the
expression of Vegf receptors such as kdrl (Pham et al., 2007;
Sumanas and Lin, 2006), the timing and level of etv2 expression
may determine when and which angioblasts are competent to
respond to Vegf signaling. Since lateral angioblasts initiate kdrl
expression later and at lower levels compared to the medial
angioblasts, this may be an important factor that prevents lateral
progenitors from acquiring an arterial fate. In addition, medial
angioblasts are exposed longer to Vegf signaling before migra-
tion, and short exposure of lateral angioblasts during migration
may not be sufficient to induce arterial differentiation.
Interestingly, time-lapse imaging of Tg(etv2:GFP) embryos
has identified additional migration behaviors. Our results show
that the anterior trunk angioblasts migrate to the midline first,
followed by the posterior angioblasts. At the onset of migra-
tion, angioblasts initially cluster around the somites, and at the
time of migration appear to ingress between the boundaries of
adjacent somites. This migration behavior was not specific to
the Tg(etv2:GFP) line, as the intersomitic migration of endothe-
lial cells was also observed in Tg(fli1a:GFP) embryos. Howlopmental Cell 25, 196–206, April 29, 2013 ª2013 Elsevier Inc. 203
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Figure 7. A Model for Arterial-Venous
Differentiation
At the 10-somite stage endothelial progenitor cells
are positioned within the LPM in two bilateral lines,
a medial (red) and lateral line (blue). After the 10-
somite stage, medial angioblasts migrate inter-
somitically to the midline directly to the dorsal
position where they differentiate as arterial cells.
Shortly after the 15-somite stage, the lateral
angioblasts migrate to the ventral position at the
midline where they differentiate as venous endo-
thelial cells. Hh, expressed in the notochord;
VegfA, expressed in the ventral somites function
as morphogens and are important for specifying
arterial fate in the medial angioblasts.
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regulated by attraction and repulsion cues between plexin and
semaphorin signaling (Gu et al., 2005; Shoji et al., 2003).
Our cell-tracking and fate-mapping data show that the majority
of medial and lateral angioblasts migrate directly to dorsoventral
positions corresponding to the future DA and PCV location.
Althoughwedidnotobserveanyendothelial progenitorsundergo-
ing ventral sprouting, we cannot exclude a possibility that some
red photoconverted cells observed in the PCV originated from
ventral sprouting as reported previously (Herbert et al., 2009).
Our analysis did not specifically focus on this event, and the imag-
ing methods, embryonic stages, as well as the region analyzed
were different from the previous study (Herbert et al., 2009).
Considering that kdrl is only weakly expressed in the venous pro-
genitors, thismay explain why directmigrationwas not previously
observed when the kdrl:GFP line was used (Herbert et al., 2009).
In higher vertebrates such as mouse and chick, arteries also
differentiate earlier than veins similar to zebrafish. Differently
from zebrafish embryos, the DA and PCV are initially paired ves-
sels and fuse only during the later stages (Garriock et al., 2010;
Gerety and Anderson, 2002; Meadows et al., 2012; Sabin,
1917). In amniotes, both the paired DA and PCV are thought to
originate through vasculogenesis when individual angioblasts
coalesce into the axial vessels; however, the details are still
poorly understood. Interestingly, the paired PCV are positioned
more laterally than the paired DA in amniotes, which is similar
to the arrangement of themedial and lateral angioblasts in zebra-
fish. Although angioblasts coalesce into axial vessels in different
anatomical locations in zebrafish compared to amniotes, it is
likely that the sites where arterial and venous progenitors origi-
nate and the molecular mechanisms of establishing arterial-
venous identity are evolutionarily conserved.
This study revisesour currentunderstandingof howendothelial
progenitor cells assemble into themajor axial vessels anddefines
the molecular mechanism by which they acquire arterial-venous
identity. Considering that many of the cellular and molecular
mechanisms that governarterial-venousdifferentiationareevolu-
tionarily conserved, our findings will be important for future
studies of vascular formation in other vertebrate systems.EXPERIMENTAL PROCEDURES
Fish Lines and Embryos
Tg(etv2:GFP)ci1, Tg(fli1a:GFP)y1(Lawson and Weinstein, 2002), and Tg(kdrl:
mcherry)ci5 transgenic lines (Proulx et al., 2010) were used to obtain embryos204 Developmental Cell 25, 196–206, April 29, 2013 ª2013 Elsevier Ifor imaging. Embryos were raised at 24C for time-lapse imaging or ISH. To
make etv2:Kaede line, the BAC construct was prepared as previously reported
(Proulx et al., 2010) with modifications to the pLD53.SC2 shuttle vector.
Modifications included the excision of EGFP from pLD53.SC2 using BamHI
and SacI. Kaede was PCR amplified from pCS2+:Kaede (kindly donated by
Dr. Joshua Waxman, CCHMC) using 50-gatttggtgacactatag-30 (fwd) 50-taa
taactcactataggg-30 (rvr) with flanking BamHI and SacI sites, and directionally
cloned into the EGFP site of pLD53.SC2. Modified BAC DNA was linearized
with AsiSI and injected into zebrafish embryos. One stable transgenic carrier
Tg(etv2:Kaede)ci6 was identified by screening. Zebrafish work was performed
under the protocols approved by the Institutional Animal Care and Use
Committee (IACUC) within the Cincinnati Children’s Hospital Research
Foundation.
Etv2 Caged Morpholino Injections and Photoactivation
We mixed 500 mM of Caging strand (Supernova Life Sciences) designed
against etv2 MO2 (Sumanas and Lin, 2006) with 50 mM of etv2 MO2 in 13
Danieau buffer (Nasevicius and Ekker, 2000). The mixture was denatured at
70C for 30 min and then was allowed to anneal overnight at 4C. We injected
2.5nl of the etv2 caging strand-MO solution into zebrafish embryos at the 1- to
2-cell stage. All solutions and injections were handled in the dark, and room
and microscope lights were equipped with yellow filters to prevent the spon-
taneous uncaging of caged etv2 morpholino. Injected embryos were kept in
the dark until uncaging. Photoactivation was performed by exposing the
injected embryos to 365 nm UV light for 30 min. A control etv2 MO2 was
prepared in the same way without adding the caging strand.
In Situ Hybridization
In situ hybridization was performed as previously described (Jowett, 1999).
Previously published etv2 (Sumanas et al., 2005), kdrl (Thompson et al.,
1998), fli1a (Thompson et al., 1998), grl (Zhong et al., 2000), gata1 (Detrich
et al., 1995), mrc1 (Wong et al., 2009), efnb2a, and ephb4a (Lawson et al.,
2001) probes were used. Prior to imaging, zebrafish embryos were dehydrated
in 100% ethanol and flat mounted in araldite. For image acquisition, processed
embryos were mounted in 2% methylcellulose or 0.6% low melting agarose
and imaged with the AxioImager compound microscope (Carl Zeiss) equipped
with a Plan-Neofluar 103/0.3 NA microscope objective (Carl Zeiss) and an
AxioCam Icc3 color camera (Carl Zeiss). During image acquisition a series
of z-planes were acquired to produce extended focus projected images.
Projected images were produced in AxioVision 4.6 software (Carl Zeiss).
Time-Lapse Confocal and Structured Illumination Imaging
For time-lapse imaging all embryos were mounted in 0.6% low melting
agarose containing 0.002% Tricaine (Sigma). Imaging was done at a temper-
ature ranging from 26C to 32C. Time-lapse confocal imaging of Tg(etv2:GFP;
kdrl:mcherry),Tg(etv2:GFP), and photoconverted etv2:Kaede-injected em-
bryos was performed using the NLO LSM 510 (Carl Zeiss), LSM 510 (Carl
Zeiss), LSM 710 (Carl Zeiss), or the Nikon D-Eclipse C1 (Nikon Instruments)
microscopes. Confocal images were acquired using the 488 and 561 nm laser
lines equipped with a Plan Aprochromat 203/0.8 NA microscope objective
(Carl Zeiss) and a Plan Aprochromat 203/0.75 NA microscope objective
(Nikon Instruments). The captured optical z-slice thickness ranged from
0.3 to 1 mm. Acquired time-lapse movies were either deconvolved using
AutoQuant X.2.2 (Media Cybernetics) and saved as maximum intensity pro-
jected over time (MIPt), or directly saved asMIPt without deconvolution. Savednc.
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LSM viewer (Carl Zeiss), or ImageJ (NIH, USA). Time-lapse structured illumina-
tion imaging was done using the Zeiss Apotome unit (Carl Zeiss) equippedwith
a Plan-Neofluar 53/0.13 NA microscope objective and an AxioCam MRm
monochrome camera (Carl Zeiss). Time-lapse files were processed in LSM
viewer and ImageJ. Frame rate adjustments, video rotation, and video sizing
were done using VirtualDub (http://www.virtualdub.com) software.
etv2:Kaede Photoconversions
etv2:Kaede embryos were injected at the 1- to 2-cell stage with 50 pg of 1:1
mixture of vegfa121 and vegfa165 RNA, or 200 pg of shhmRNA, or 10 ng vegfa
ATG-MO (Nasevicius and Ekker, 2000) or treated in 100 mM cyclopamine from
50% epiboly to 26 somites. Whole-embryo photoconversions were performed
at 14- to 15-somites using an AxioImager compound microscope equipped
with a Plan-Neofluar 53 objective. Embryos were exposed to the DAPI filter
setting for 10–15 s. For photoconversion of groups of medial angioblasts,
embryos were mounted in 0.6% low melting agarose containing 0.002%
Tricaine. Using an LSM 710 equipped with a Plan Aprochromat 203/0.8 NA
objective, small groups of cells were selected and exposed to 405 nm laser
light. Photoconverted embryos (24–26 hpf) were mounted in 0.6% low melting
agarose or 3% methylcellulose with 0.004% Tricaine and imaged using either
an AxioImager compoundmicroscope equipped with a Plan-Neofluar 103/0.3
NA objective and an AxioCamMRm camera or a Nikon-D Eclipse C1 confocal
microscope. Images were analyzed and processed using AxioVision and
Photoshop software. For wild-type and DMSO-treated embryos, cells were
categorized based on position within the dorsal aorta or posterior cardinal
vein. In experimental embryos that did not form distinct DA and PCV vessels,
cells were scored based on their dorsoventral position within the single vessel.
Because it was not always possible to clearly distinguish boundaries between
the neighboring cells, the cell counts are approximate estimates. Percentage
values were calculated for the total number of Kaede cells in all embryos
analyzed.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and eight movies and can
be found with this article online at http://dx.doi.org/10.1016/j.devcel.2013.
03.017.
ACKNOWLEDGMENTS
We thank C. Closson andM. Kofron for assistance with imaging, S.C. Ekker for
shh construct, and J. Waxman for ephrin2b probe. This research was sup-
ported by NIH grant R01 HL107369-01 to S.S. and AHA Great Rivers Chapter
Award 12POST12040123 to V.K. V.K., J.A.S., S.P.D., and K.R. performed ex-
periments, analyzed the resulting data, and provided critical comments; S.S.
designed the study, performed experiments, and analyzed the data; V.K.,
J.A.S., and S.S. wrote the paper.
Received: March 30, 2012
Revised: January 14, 2013
Accepted: March 25, 2013
Published: April 29, 2013
REFERENCES
Ando, R., Hama, H., Yamamoto-Hino, M., Mizuno, H., andMiyawaki, A. (2002).
An optical marker based on the UV-induced green-to-red photoconversion of
a fluorescent protein. Proc. Natl. Acad. Sci. USA 99, 12651–12656.
Childs, S., Chen, J.N., Garrity, D.M., and Fishman, M.C. (2002). Patterning of
angiogenesis in the zebrafish embryo. Development 129, 973–982.
Cleaver, O., and Krieg, P.A. (1998). VEGF mediates angioblast migration
during development of the dorsal aorta in Xenopus. Development 125,
3905–3914.
Covassin, L., Amigo, J.D., Suzuki, K., Teplyuk, V., Straubhaar, J., and Lawson,
N.D. (2006). Global analysis of hematopoietic and vascular endothelial gene
expression by tissue specific microarray profiling in zebrafish. Dev. Biol.
299, 551–562.DeveDetrich, H.W., 3rd, Kieran, M.W., Chan, F.Y., Barone, L.M., Yee, K.,
Rundstadler, J.A., Pratt, S., Ransom, D., and Zon, L.I. (1995). Intraembryonic
hematopoietic cell migration during vertebrate development. Proc. Natl.
Acad. Sci. USA 92, 10713–10717.
Ekker, S.C., Ungar, A.R., Greenstein, P., von Kessler, D.P., Porter, J.A., Moon,
R.T., and Beachy, P.A. (1995). Patterning activities of vertebrate hedgehog
proteins in the developing eye and brain. Curr. Biol. 5, 944–955.
Eriksson, J., and Lo¨fberg, J. (2000). Development of the hypochord and dorsal
aorta in the zebrafish embryo (Danio rerio). J. Morphol. 244, 167–176.
Fouquet, B., Weinstein, B.M., Serluca, F.C., and Fishman, M.C. (1997). Vessel
patterning in the embryo of the zebrafish: guidance by notochord. Dev. Biol.
183, 37–48.
Garriock, R.J., Czeisler, C., Ishii, Y., Navetta, A.M., and Mikawa, T. (2010). An
anteroposterior wave of vascular inhibitor downregulation signals aortae
fusion along the embryonic midline axis. Development 137, 3697–3706.
Gerety, S.S., and Anderson, D.J. (2002). Cardiovascular ephrinB2 function is
essential for embryonic angiogenesis. Development 129, 1397–1410.
Gering,M., Rodaway, A.R., Go¨ttgens, B., Patient, R.K., andGreen, A.R. (1998).
The SCL gene specifies haemangioblast development from early mesoderm.
EMBO J. 17, 4029–4045.
Goll, M.G., Anderson, R., Stainier, D.Y., Spradling, A.C., and Halpern, M.E.
(2009). Transcriptional silencing and reactivation in transgenic zebrafish.
Genetics 182, 747–755.
Gu, C., Yoshida, Y., Livet, J., Reimert, D.V., Mann, F., Merte, J., Henderson,
C.E., Jessell, T.M., Kolodkin, A.L., and Ginty, D.D. (2005). Semaphorin 3E
and plexin-D1 control vascular pattern independently of neuropilins. Science
307, 265–268.
Hatta, K., Tsujii, H., and Omura, T. (2006). Cell tracking using a photoconver-
tible fluorescent protein. Nat. Protoc. 1, 960–967.
Herbert, S.P., Huisken, J., Kim, T.N., Feldman, M.E., Houseman, B.T., Wang,
R.A., Shokat, K.M., and Stainier, D.Y. (2009). Arterial-venous segregation by
selective cell sprouting: an alternative mode of blood vessel formation.
Science 326, 294–298.
Hogan, B.M., Bos, F.L., Bussmann, J., Witte, M., Chi, N.C., Duckers, H.J., and
Schulte-Merker, S. (2009). Ccbe1 is required for embryonic lymphangiogene-
sis and venous sprouting. Nat. Genet. 41, 396–398.
Jin, S.W., Beis, D., Mitchell, T., Chen, J.N., and Stainier, D.Y. (2005). Cellular
and molecular analyses of vascular tube and lumen formation in zebrafish.
Development 132, 5199–5209.
Jowett, T. (1999). Analysis of protein and gene expression. Methods Cell Biol.
59, 63–85.
Krauss, S., Concordet, J.P., and Ingham, P.W. (1993). A functionally
conserved homolog of the Drosophila segment polarity gene hh is expressed
in tissues with polarizing activity in zebrafish embryos. Cell 75, 1431–1444.
Laale, H.W. (1977). The biology and use of zebrafish, Brachydanio rerio in
fisheries research. J. Fish Biol. 10, 121–173.
Lawson, N.D., and Weinstein, B.M. (2002). In vivo imaging of embryonic
vascular development using transgenic zebrafish. Dev. Biol. 248, 307–318.
Lawson, N.D., Scheer, N., Pham, V.N., Kim, C.H., Chitnis, A.B., Campos-
Ortega, J.A., and Weinstein, B.M. (2001). Notch signaling is required for
arterial-venous differentiation during embryonic vascular development.
Development 128, 3675–3683.
Lawson, N.D., Vogel, A.M., and Weinstein, B.M. (2002). sonic hedgehog and
vascular endothelial growth factor act upstream of the Notch pathway during
arterial endothelial differentiation. Dev. Cell 3, 127–136.
Lee, D., Park, C., Lee, H., Lugus, J.J., Kim, S.H., Arentson, E., Chung, Y.S.,
Gomez, G., Kyba, M., Lin, S., et al. (2008). ER71 acts downstream of BMP,
Notch, and Wnt signaling in blood and vessel progenitor specification. Cell
Stem Cell 2, 497–507.
Leung, A., Ciau-Uitz, A., Pinheiro, P., Monteiro, R., Zuo, J., Vyas, P., Patient,
R., and Porcher, C. (2013). Uncoupling VEGFA functions in arteriogenesis
and hematopoietic stem cell specification. Dev. Cell 24, 144–158.lopmental Cell 25, 196–206, April 29, 2013 ª2013 Elsevier Inc. 205
Developmental Cell
Origin of Arterial and Venous ProgenitorsLiang, D., Xu, X., Chin, A.J., Balasubramaniyan, N.V., Teo, M.A., Lam, T.J.,
Weinberg, E.S., and Ge, R. (1998). Cloning and characterization of vascular
endothelial growth factor (VEGF) from zebrafish, Danio rerio. Biochim.
Biophys. Acta 1397, 14–20.
Liang, D., Chang, J.R., Chin, A.J., Smith, A., Kelly, C., Weinberg, E.S., and Ge,
R. (2001). The role of vascular endothelial growth factor (VEGF) in vasculogen-
esis, angiogenesis, and hematopoiesis in zebrafish development. Mech. Dev.
108, 29–43.
Liao, E.C., Paw, B.H., Oates, A.C., Pratt, S.J., Postlethwait, J.H., and Zon, L.I.
(1998). SCL/Tal-1 transcription factor acts downstream of cloche to specify
hematopoietic and vascular progenitors in zebrafish. Genes Dev. 12, 621–626.
Meadows, S.M., Fletcher, P.J., Moran, C., Xu, K., Neufeld, G., Chauvet, S.,
Mann, F., Krieg, P.A., and Cleaver, O. (2012). Integration of repulsive guidance
cues generates avascular zones that shape mammalian blood vessels. Circ.
Res. 110, 34–46.
Nasevicius, A., and Ekker, S.C. (2000). Effective targeted gene ‘knockdown’ in
zebrafish. Nat. Genet. 26, 216–220.
Nasevicius, A., Larson, J., and Ekker, S.C. (2000). Distinct requirements for
zebrafish angiogenesis revealed by a VEGF-A morphant. Yeast 17, 294–301.
Pham, V.N., Lawson, N.D., Mugford, J.W., Dye, L., Castranova, D., Lo, B., and
Weinstein, B.M. (2007). Combinatorial function of ETS transcription factors in
the developing vasculature. Dev. Biol. 303, 772–783.
Proulx, K., Lu, A., and Sumanas, S. (2010). Cranial vasculature in zebrafish
forms by angioblast cluster-derived angiogenesis. Dev. Biol. 348, 34–46.
Sabin, F.R. (1917). Origin and development of the primitive vessels of the chick
and of the pig. Contrib. Embryol. 6, 61–124.
Serbedzija, G.N., Flynn, E., and Willett, C.E. (1999). Zebrafish angiogenesis: a
new model for drug screening. Angiogenesis 3, 353–359.
Shoji, W., Isogai, S., Sato-Maeda, M., Obinata, M., and Kuwada, J.Y. (2003).
Semaphorin3a1 regulates angioblast migration and vascular development in
zebrafish embryos. Development 130, 3227–3236.
Stark, D.A., and Kulesa, P.M. (2007). An in vivo comparison of photoactivat-
able fluorescent proteins in an avian embryo model. Dev. Dyn. 236, 1583–
1594.
Sumanas, S., and Lin, S. (2006). Ets1-related protein is a key regulator of vas-
culogenesis in zebrafish. PLoS Biol. 4, e10.
Sumanas, S., Jorniak, T., and Lin, S. (2005). Identification of novel vascular
endothelial-specific genes by the microarray analysis of the zebrafish cloche
mutants. Blood 106, 534–541.
Sumanas, S., Gomez, G., Zhao, Y., Park, C., Choi, K., and Lin, S. (2008).
Interplay among Etsrp/ER71, Scl, and Alk8 signaling controls endothelial
and myeloid cell formation. Blood 111, 4500–4510.206 Developmental Cell 25, 196–206, April 29, 2013 ª2013 Elsevier ISwift, M.R., and Weinstein, B.M. (2009). Arterial-venous specification during
development. Circ. Res. 104, 576–588.
Thisse, B.T., and Thisse, C. (2004). Fast Release Clones: A High Throughput
Expression Analysis. ZFIN Direct Data Submission (http://zfin.org).
Thompson, M.A., Ransom, D.G., Pratt, S.J., MacLennan, H., Kieran, M.W.,
Detrich, H.W., 3rd, Vail, B., Huber, T.L., Paw, B., Brownlie, A.J., et al. (1998).
The cloche and spadetail genes differentially affect hematopoiesis and vascu-
logenesis. Dev. Biol. 197, 248–269.
Tomasini, A.J., Schuler, A.D., Zebala, J.A., and Mayer, A.N. (2009).
PhotoMorphs: a novel light-activated reagent for controlling gene expression
in zebrafish. Genesis 47, 736–743.
Wang, H.U., Chen, Z.F., and Anderson, D.J. (1998). Molecular distinction and
angiogenic interaction between embryonic arteries and veins revealed by
ephrin-B2 and its receptor Eph-B4. Cell 93, 741–753.
Watanabe, W., Shimada, T., Matsunaga, S., Kurihara, D., Fukui, K., Shin-Ichi
Arimura, S., Tsutsumi, N., Isobe, K., and Itoh, K. (2007). Single-organelle
tracking by two-photon conversion. Opt. Express 15, 2490–2498.
Weinstein, B.M., Stemple, D.L., Driever, W., and Fishman, M.C. (1995).
Gridlock, a localized heritable vascular patterning defect in the zebrafish.
Nat. Med. 1, 1143–1147.
Wilkinson, R.N., Koudijs, M.J., Patient, R.K., Ingham, P.W., Schulte-Merker,
S., and van Eeden, F.J. (2012). Hedgehog signaling via a calcitonin receptor-
like receptor can induce arterial differentiation independently of VEGF
signaling in zebrafish. Blood 120, 477–488.
Williams, C., Kim, S.H., Ni, T.T., Mitchell, L., Ro, H., Penn, J.S., Baldwin, S.H.,
Solnica-Krezel, L., and Zhong, T.P. (2010). Hedgehog signaling induces arte-
rial endothelial cell formation by repressing venous cell fate. Dev. Biol. 341,
196–204.
Wong, K.S., Proulx, K., Rost, M.S., and Sumanas, S. (2009). Identification of
vasculature-specific genes by microarray analysis of Etsrp/Etv2 overexpress-
ing zebrafish embryos. Dev. Dyn. 238, 1836–1850.
Zhong, T.P., Rosenberg, M., Mohideen, M.A., Weinstein, B., and Fishman,
M.C. (2000). gridlock, an HLH gene required for assembly of the aorta in zebra-
fish. Science 287, 1820–1824.
Zhong, T.P., Childs, S., Leu, J.P., and Fishman, M.C. (2001). Gridlock signal-
ling pathway fashions the first embryonic artery. Nature 414, 216–220.
Zygmunt, T., Gay, C.M., Blondelle, J., Singh, M.K., Flaherty, K.M., Means,
P.C., Herwig, L., Krudewig, A., Belting, H.G., Affolter, M., et al. (2011).
Semaphorin-PlexinD1 signaling limits angiogenic potential via the VEGF decoy
receptor sFlt1. Dev. Cell 21, 301–314.nc.
